Cristina Müller, Roger Schibli, & Britta Maurer. (2020). Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? MDPI AG.
Chicago Style (17th ed.) CitationCristina Müller, Roger Schibli, and Britta Maurer. Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? MDPI AG, 2020.
MLA (9th ed.) CitationCristina Müller, et al. Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.